A new study sheds light onto a fundamental mechanism underlying the development of Alzheimer's disease. Researchers believe the findings could lead to new forms of therapy for those living with the disease.
Researchers have identified a new pathway that can dampen the production of amyloid beta.
Findings promising as a potential early therapeutic intervention for AD.
A new study suggests amylin could be a second amyloid and a new biomarker for age related dementia and Alzheimer's disease.
Researchers combine data from four different NMR techniques to observe chaperone GroEL capture a disordered beta-amyloid protein.
While evidence suggests pathological proteins linked to the onset and progression of neurodegenerative disorders are capable of spreading from cell-to-cell within the brains of affected individuals, new research shows no evidence to support concerns that these abnormal disease proteins are “infectious” or transmitted from animals to humans or from one person to another.
